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MetastaticAbstract Purpose: To demonstrate many uncommon, non-classical clinical presentations of HCC
that have been gathered from an endemic region in the Nile Basin.
Patients and methods: We will highlight cases of high quality MDCT performed for various clinical
symptoms not classically associated with advanced or metastatic HCC and the role of image-guided
biopsy in diagnoses. These include: (a) gradual progressive weakness of lower limbs; (b) Retroster-
nal pain not responding to medications; (c) severe right hip pain; (d) progressive cheek swelling.
These symptoms further corresponded to musculoskeletal abnormalities, not typically associated
with HCC, including: (a) lumbar spinal cord compression by expansile vertebral body lesion; (b)
direct invasion of chest wall; (c) large expansile metastasis of right acetabulum; (d) expansible rib
lesions with rib destruction, (e) painful cheek swelling.
Results: In numerous patients with a range of non-speciﬁc musculoskeletal complaints and various
clinical presentations, the ﬁnal diagnosis was HCC. The clinical presentation was dependent on
uncommon skeletal deposits which were often expansile with the local effect of compression as
underlying cause for the odd presentation. The important role of MDCT and Histopathological
assessment in making correct diagnosis will be stressed.
Conclusion: HCC can often grow silently and may present late with odd non-classic clinical presen-
tation.
 2014 The Egyptian Society of Radiology and Nuclear Medicine. Production and hosting by Elsevier
B.V.Open access under CC BY-NC-ND license.1. Introduction
Hepatocellular carcinoma (HCC) is one of the most common
malignant tumors worldwide (1). Major etiologic factors asso-
ciated with HCC include infection with hepatitis C (HCV) and
hepatitis B (HBV) viruses, excess alcohol intake and aﬂatoxin
B1 exposure (2,3). HCC, with and without HCV infection,
represents a major health problem in Egypt, where the two
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Egypt, the incidence of HCC is increasing according to the
National Cancer Institute records; the incidence of liver cancer
is 21.9 and 4.5 per 1,00,000 per year in males and females
respectively.
HCC causes about 1 million deaths each year worldwide.
Patients usually present at an advanced stage when the growth
is irresectable as there are no early presenting symptoms and
because of its great propensity for intra-biliary and intravascu-
lar invasion even when the tumor is small (5).
Metastasis from HCC occurs by hematogenous and lym-
phatic routes. Extra hepatic hematogenous metastasis indi-
cates poor prognosis, it occurs in approximately 37% of
patients. Common sites of metastatic spread include the lungs,
intra-abdominal organs, bones, adrenals, lymph nodes, perito-
neum and, rarely, skeletal muscle. Together spread of disease
to the bones and muscle accounts for approximately 16% of
all metastases. Metastasis to the skeletal muscles is extremely
rare (6–8), especially chest wall muscles, gluteus muscle and
anterior abdominal wall muscles.
Bone metastases from HCC are common and the incidence
may range from 1 to 20% (9). Less frequently, bone metastases
may be the ﬁrst symptom of HCC. Bone metastases, isolated
or multiple, from unknown primary HCC are exceptional
and only a few case reports have been documented (9–12).
The aim of this study is to highlight and demonstrate many
uncommon, non-classical clinical presentations of HCC that
have been gathered from an endemic region in the Nile Basin.
2. Patients and methods
2.1. Patients
This study was approved by the ethics committee of our insti-
tution during the period between 2009 and 2013. It included
45 patients collected and selected retrospectively from about
three hundred patients who came to the outpatient CT suite
and interventional radiology unit in the El Minia University
Hospital (referral hospital in upper Egypt), presented with a
variety of clinical symptoms not classically associated with
advanced or metastatic HCC. Patient age ranged from 33- 80
years, 32 were males and 13 females. Three groups of patients
were imaged for these clinical symptoms, the ﬁrst group (a)
Patients not known to be clinically or laboratory diagnosed
as HCV or HBV positive and their ﬁrst diagnosis by imaging
was metastatic HCC. Second group; (b) Patients clinically
and laboratory diagnosed as chronic liver disease (CLD), and
their presentation was the metastatic complications of HCC.
Third group; (c) patients clinically diagnosed as HCC, some
of these patients were under various lines of percutaneous min-
imally invasive therapies (TACE and RF ablation). Skeletal
metastatic manifestations were diagnosed during follow up as
disease progression by imaging follow up.
Various clinical manifestations draw our attention to these
skeletal metastasis included: (a) gradual progressive weakness
of both lower limbs; (b) retrosternal pain not responding to
medications and painful chest wall swellings; (c) severe hip
and sciatic pain; and (d) progressive cheek swelling. These
symptoms further corresponded to musculoskeletal abnormal-
ities, not typically associated with HCC, including: (a) lumbar
spinal cord compression by an expansile vertebral body
lesions; (b) direct invasion of the chest wall; (c) a large expan-sile metastasis of the acetabulum and iliac bones; (d) expansi-
ble rib lesions with underlying rib destruction, and (e) painful
cheek swelling.
High quality MDCT for the skeletal lesions was performed
for all patients with the previous clinical symptoms that were
not classically associated with advanced or metastatic HCC.
Image-guided biopsy was performed for all patients from the
metastatic lesions to conﬁrm the diagnosis of HCC, to decide
if we are going to perform ultrasound and multiphasic contrast
MDCT imaging studies for patient’s liver searching for pri-
mary hepatic lesions.
2.2. Procedures
– Skeletal imaging using monophasic continuous scan after
IV contrast material injection
– Multiphasic MDCT imaging of the liver was performed in
hepatic arterial phase (HAP), portal vein inﬂow phase,
and portal venous phase (PVP).
– CT, US guided tissue biopsy and histopathological assess-
ment were the corner stone in our study to conﬁrm the cor-
rect diagnosis of metastatic HCC in various parts of the
skeleton and accordingly, we proceeded to further steps in
the diagnosis of HCC, more skeletal survey to search for
more skeletal lesions. Image guided biopsy was done for
the patients of the ﬁrst group and most of the patients of
second group.
2.2.1. CT guided biopsy technique
Patients lie in a proper position according to the lesion loca-
tion on the CT scanner couch. For the lesions in the spine,
patients were in a prone position and the back was dripped
well by disinfectant (Betadine) for at least 5 min. The lesion
of interest was imaged to localize the target area for biopsy,
and then skin mark was put to start the procedure by inﬁltra-
tion of local anesthetic agent starting from the skin deeply to
the level of the periosteum to reduce pain. Co axial system
was introduced to deliver the cutting needle to the region of
interest. This co axial system was introduced using a CT ﬂuo-
roscopy monitor in the CT suite (Bright Speed 16; GE Medical
Systems). In cases of lesions with eroded bony cortex, intro-
duction of the semi-automatic biopsy needle was done through
co axial system to perform biopsy directly. At least two tissue
cores were taken from the center and the periphery of the
lesion to guarantee the presence of enough malignant tissue
in the sample. In cases with intact bony cortex semiautomatic
needle was not able to puncture the cortex and manual drilling
by using bone biopsy set was used to take a full thickness core
involving the cortex and the lytic portion of the lesion. (Bone
biopsy needles were supplied by the same manufactures of the
semiautomatic biopsy needle).
The biopsies are performed by using a 16-gauge core biopsy
needle (Disposable semiautomatic biopsy instrument with
variable throw, GMT GT50, German Medical technology
(Beijing) Co., Ltd.,). All NCBs were performed in a similar
fashion using ultrasound or CT guidance to determine the
needle position within the lesion. NCBs were collected into
formalin, processed, sectioned, stained with hematoxylin and
eosin and mounted using a DPX mounting medium. Represen-
tative sections were photographed under bright ﬁeld optics
using an Olympus light microscope.
Fig. 1 Patient from the ﬁrst group, presented with progressive lower limb weakness, (A,B) MDCT sagittal and coronal images of the
lumbar spine showing solitary expanding lytic bony lesion involving the posterior portion of the vertebral body of the 5th lumbar vertebra
with epidural component compressing the thecal sac. The pedicles are spared. (C) Axial CT image showing multiple enhanced lesions in
the arterial phase of contrast enhancement. (D) Hematoxylin and eosin-staining of a representative moderately differentiated
hepatocellular carcinoma sections showing groups of hepatocytes forming a thickened trabecular pattern lined by endothelial cells. The
hepatocytes have increased nuclear/cytoplasmic (N:C) ratio and occasional prominent nucleoli.
Table 1 Acquisition parameters of a 16-detector MDCT scanner (Bright Speed 16; GE Medical Systems).
Phase Thick
speed
Interval mm FOV kV mA Total
exposure
time
Start
preparation
Scan
type
Beam
collimation
(mm)
Detector
conﬁguration
Helical
thicknes
(mm)s
Row Pitch Speed
(mm/rot)
Arterial 5 16 1.375:1 27.5 5 Large 120 380 7.9 25 s Helical full 0.8 s 20.0 16 · 1.25
Portal 5 16 1.375:1 27.5 5 Large 120 380 13.7 65 s Helical full 0.8 s 20.0 16 · 1.25
Delayed 5 16 1.375:1 27.5 5 Large 120 380 7.9 3 min Helical full 0.8 s 20.0 16 · 1.25
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2.3.1. Imaging and image processing techniques
2.3.1.1. Imaging acquisition. CT studies were performed using a
16-detector MDCT scanner (Bright Speed 16; GE Medical
Systems). The liver was scanned with a single breath-hold of
20-25 s. Contrast material was injected with a power injector
(Medrad, Stellant) through an 18- or 20-gauge catheter into
the antecubital vein. The injection rate was 3 mL/s. A total
of 80-120 mL of nonionic contrast material was used. A timing
bolus tracking technique was employed. The acquisition
parameters were summarized in Table 1.
2.3.1.2. Image reconstruction. For image reconstruction, the
axial source images with a 5 mm slice were transferred to an
Advantage Workstation (AW) Volume Share 2 (GE Health-
care). Multiplanar reformatted images (MPR) images were
obtained in the coronal and sagittal planes with a section
thickness of 5 mm (Table 1).Fig. 2 Patient from the second group, presented with retro sterna
sagittal images of the upper abdomen and the lower chest showing left
which is seen inseparable from the posterior portion of the lower
representative moderately differentiated hepatocellular carcinoma secti
pattern lined by endothelial cells. The hepatocytes have increased nuc3. Results
In the selected group of patients with a wide range of
non-speciﬁc musculoskeletal complaints and various clinical
presentations, the ﬁnal diagnosis was HCC. The clinical
presentation was dependent on uncommon skeletal deposits
which were most often expansile with the local effect of
compression as the underlying cause for the odd presentation
(see Figs. 1–7).
First group of patients was surprisingly diagnosed as
skeletal metastasis from HCC while they were not previously
diagnosed as chronic liver disease or HCC patients. This
group included 11 patients, 7 patients were complaining of
lower limb related manifestations ranged from unrelieved
sciatic pain to various degrees of lower limb weakness,
imaging revealed expansile lytic bony lesions involving the
vertebral bodies extending and compressing the adjacent
bony lumbar canal and neural exit foramen, associated with
a large soft tissue component extending to the para spinall pain not responding to medications, (A,B,C) MDCT axial and
lobe hepatic lesions with direct extension to the retro sternal region
chest wall (sternum). (D) Hematoxylin and eosin-staining of a
ons showing groups of hepatocytes forming a thickened trabecular
lear/cytoplasmic (N:C) ratio and occasional prominent nucleoli.
Fig. 3 Patient from the second group, presented with unexplained right hip joint pain, (A,B) MDCT coronal images of the pelvis
showing destructive lytic bony lesion involving the roof of the right acetabula reaching the articular surface of the right hip joint space. (D)
Axial CT image of the liver showing left lobe hepatic lesion. (D) Hematoxylin and eosin-staining of a representative moderately
differentiated hepatocellular carcinoma sections showing groups of hepatocytes forming a thickened trabecular pattern lined by
endothelial cells. The hepatocytes have increased nuclear/cytoplasmic (N:C) ratio and occasional prominent nucleoli.
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swelling involving and destructing the ribs with sizable soft
tissue component, one patient complained of headache
associated with painful skull swelling and the referring neuro-
surgeon asked for CT brain with bone window for the skull,
the lesion found as a soft expanding lytic bony lesion
destructing the underlying skull bone with involvement of
the dural coverings and small intra cranial extension. Two
patients in this group were persistently complaining of hip
joint pain and the referring orthopedic surgeon asked for
scanning pelvis and hip joints for osteoarthritis, the result
was destructive, expansile lytic bony lesions at the acetabular
roof extending to the joint space (Table 2). Diagnosis in this
group was suspected clinically and conﬁrmed by high quality
MDCT images, biopsy was crucial as a ﬁnal conﬁrming
diagnostic tool to proceed to a further step to scan the liver
searching for HCC diagnosis which was odd.
Second group; patients were previously diagnosed as
chronic liver disease (CLD) either HCV or HBV positivecarriers, they were on follow up schedule and medical treat-
ment, the indications for CT scanning was either the site of
complain or the rising level of alpha fetoprotein in their
serum. This group included 15 patients (Table 2), seven
patients were diagnosed as spinal deposits with various
degrees of compression on the thecal sac, spinal cord, and
neural exit foramina as well as para vertebral soft tissue com-
ponent. Three patients were complaining of painful rib swell-
ings, one patient of unexplained retro sternal pain not
responding to medications, scanning the abdomen and the
lower chest revealed left hepatic lobe hepatoma directly
invading the lower part of the anterior chest wall. Three
patients presented with skull vault and facial swellings. One
patient presented with painful left iliac bone swelling extend-
ing to the adjacent ischio-rectal fossa (Table 2). Diagnosis in
this group was relatively easier as the previous medical
background made clinical suspicious directed toward the
presence of CLD and its complications, metastatic HCC
was the diagnosis both radiologically and pathologically.
Fig. 4 Patient from the third group, presented with progressive lower limb weakness and pain at the right iliac and lumbar region (A–C)
MDCT sagittal and coronal images of the lumbar spine and iliac bone showing multiple expanding lytic bony lesions involving the
vertebral bodies and iliac bones with sizable soft tissue components. (D) Axial CT image of the liver during the arterial phase of contrast
showing enhanced hepatic lesion and lytic lesion seen involving the pedicle of the lumbar vertebra in the same cut. (E) Hematoxylin and
eosin-staining of a representative well-differentiated hepatocellular carcinoma sections showing acinar like and branched trabecular
patterns of hepatocytes with minimal atypia. Prominent capillaries are noted within the sheets and endothelial cells are noted to be
encircling clusters of hepatocytes.
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complicated by HCC on top, they were either on follow up
or under treatment. In these 19 patients MDCT imaging
revealed lytic bony lesions in different regions in the skeleton
related to their site of complain. 12 out of 19 patients
underwent MDCT scanning for the liver to asses treatment
outcome after minimally invasive therapies (TACE and RF
ablation), lytic spinal and pelvic lesions were encountered
as disease progression after TACE and or RF ablation in
the form of distant skeletal metastasis of the same characters
described in the ﬁrst group. Two patients had painful
expanding rib swelling, two developed disﬁguring skull swell-
ings one showed ulcerated overlying skin, the oncologist
referred them as a part of metastatic work up. Two patients
suffered from pelvic pain, the imaging results revealed
acetabular and iliac lesions destructing bones (Table 2).
Diagnosis in this group was much easier as the patients were
already known to be HCC under follow up schedule or
under treatment, distant metastasis was considered a diseaseprogression or treatment failure and biopsy was not done in
this group.
Twenty-nine patients had single metastatic lesions, while 16
patients had multiple lesions at different parts of the skeleton.
The number and distribution of bone metastasis and their site
of preference were summarized in (Table 3).
4. Discussion
HCV, HBV and the resulting chronic liver disease are the
most distressing health problems in Egypt in the recent
decades, HCC is the terminal complication of CLD in most
patients. Lack of medical care, health insurance, poverty
and low socioeconomic standard add a heavy burden for
the problem, making the patient to seek medical advice very
late in the disease course, always after the appearance of
complications.
Few data in the literatures are available about skeletal
metastasis of HCC that make this kind of odd presentation
Fig. 5 Patient from the third group, presented with painful chest wall and back swelling, (A,B) MDCT Axial and coronal images of the
chest wall showing expanding lytic bony lesion involving the ribs and vertebral body of the dorsal spine encroaching upon the posterior rib
articulations and chest cavity. (C) Axial CT image showing sizable heterogeneous right hepatic lobe lesion. (D) Hematoxylin and eosin-
staining of a representative well-differentiated hepatocellular carcinoma sections showing acinar like and branched trabecular patterns of
hepatocytes with minimal atypia. Prominent capillaries are noted within the sheets and endothelial cells are noted to be encircling clusters
of hepatocytes.
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the ﬁrst group of the study presented by the complications
without previous knowledge of being chronic liver patients
and most of them were HBV positive carriers.
The frequency and distribution of bony metastases from
HCC in this study were peculiar, especially in the ﬁrst group
that included 11 patients, in whom the ﬁrst symptoms were
bony metastases from unknown primary, HCC. Eleven
patients is a considerable number compared to the published
data by Qureshi (13) who reported that bony metastases as a
ﬁrst presentation of unknown HCC is rare and exceptional
and only reported in very few case reports. Moreover the
addition of image guided biopsy and microscopic conﬁrma-
tion add more strength in proving the odd skeletal metastases
in 26 patients (1st and 2nd groups) from undiagnosed HCC
in one clinical study in a four year time interval compared
with the study by Kim (14) which included 53 patients over
10 years, our hospital is a referral hospital that made the timeinterval of our study groups of patients shorter compared
with the others.
The characteristic MDCT imaging features of nearly all the
detected skeletal metastases were large, destructive, osteolytic
lesions with expansile soft tissue formation that exert compres-
sion of the underlying structure resulting in speciﬁc clinical
presentations that correspond to the presenting clinical
complaints of each patient, as progressive lower limb weakness
due to spinal compression and resistant retrosternal pain due
to direct sternal invasion from left hepatic lobe lesion. Some
studies with a limited number of patients have described the
characteristics of bone metastasis from HCC, such as soft
tissue formation (15-19). Kim (14) conﬁrmed the characteristic
ﬁnding of soft tissue formation at a bone metastasis from a
primary hepatocellular carcinoma.
Most of the metastatic bony lesions were single, they were
encountered in 29 (64.4%) out of 45 patients, while 16 patients
had multiple metastatic lesions. This nearly match study done
Fig. 6 Patient from the third group, presented with painful check swelling, (A,B) MDCT axial and coronal images showing large
expanding lytic bony lesion involving the left portion of the zygoma encroaching upon the left maxillary air sinus. (C) Axial CT image
during the arterial phase of contrast enhancement showing sizable enhanced left lobe lesion. (D) Hematoxylin and eosin-staining of a
representative metastatic hepatocellular carcinoma section shows sheets and small groups of hepatocytes with marked polymorphism and
hyperchromatism. The malignant cells are surrounded by desmoplastic reaction.
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static site, while 16 patients had multiple lesions. HCC in its
odd presentation found to have special preference to the skele-
ton, the most common was the axial skeleton (71%), vertebrae
and skull in 26 and 6 patients respectively. Dissemination of
hepatocellular carcinoma cells to the vertebra was explained
by Fukutomi (20), who reported that spread occurs through
the portal vein-vertebral vein plexuses due to the presence of
early vascular invasion mainly portal thrombus and/or portal
hypertension. HCC metastatic lesions were either solitary or
multiple with no speciﬁc order of frequency or explanation of
either. These results conceded with that of Kim (14), Fukutomi
(20), and Sneag (21), however the order of frequency and
distribution of lesions in our result was in contradiction to their
studies, a ﬁnding that may intensify the possibility of own
speciﬁc distribution pattern of skeletal metastases from HCC
in Egypt.
The second common site of metastases is the chest wall,
it was found in 8 patients, and majority of them (6 out of
8 patients) were included in the 1st and 2nd groups, this
was in contrary to the study of Qureshi (13) and Hyun(22) who postulated that bone metastases localized to the
chest wall from unknown primary hepatocellular carcinoma
are scarcely reported as anecdotal case reports in the
literature.
Metastasis to the skull frequently occurs in patients with
lung, breast and prostate cancer. However Hsieh (23) and
Chan (24) had addressed that skull metastases from HCC
have been rarely reported. In our results, skull was the third
common site of bone metastases and it was detected in 6
patients, the lesions were osteolytic for both the outer and
inner tables of the skull having extra and intra cranial
components.
Pelvic bone was the least common site of skeletal metasta-
ses, it was found in only 5 patients in contrary to previous
studies which reported that pelvic bones including the hip
joints was the 2nd most common site of bony metastases from
HCC (14,20,25).
HCC skeletal metastases in this study seem to exhibit unu-
sual non classical clinical presentation associated with HCC
resulting mostly from deposits in the axial skeleton with sec-
ondary compression effect.
Table 2 Showing various clinical groups of patients and the distribution of skeletal lesions at different regions of the bony skeleton.
Spine Chest wall Skull Pelvis
First group (11 patients) 7 2 1 1
5 lumbar spine 2 Dorsal spine 1Ribs 1stern 1Skull bone - 1acetablum -
Second group (15 patients) 7 4 3 1
6 lumbar spine 1Dorsal spine 3Ribs 1stern 1Skull bone 2 maxilla - 1iliac bone
Third group (19 patients) 12 2 2 3
11 Lumbarspine 1Dorsal spine 2Ribs - 2Skull bone 1acetabul 2iliac bone
Fig. 7 Patient from the third group, underwent TACE for right hepatic lobe lesion 6 month follow up images revealed metastatic lesions,
(A) MDCT coronal image showing dense lipidol particles in the lesion, bilateral supra renal metastatic deposits more evident at the left
side as well as lytic bony lesion seen at the 4th lumbar vertebra. (B,C) axial CT images showing expanding lytic bony lesions involving the
vertebral body of the 4th lumbar vertebral and the left iliac bone. (D) Hematoxylin and eosin-staining of a representative metastatic
hepatocellular carcinoma section shows sheets and small groups of hepatocytes with marked polymorphism and hyperchromatism. The
malignant cells are surrounded by desmoplastic reaction.
Table 3 Showing number of lesions, single or multiple and which is the site of preference by each lesion.
Single lesions % Multiple lesions % Site of predilection %
First group (11 patients) 8 patients 64.4 3 patients 35.6 Axial Skeleton 71
Lumbar Dorsal Skull Spine
Second group (15 patients) 10 patients 5 patients Axial Skelton
Lumbar Dorsal Ribs Skull
Third group (19 patients) 11 patients 8 patients Axial Skeleton
Lumbar Dorsal Skull Pelvis
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HCC is a very common terminal complication of chronic liver
disease, it can often grow silently and may present late with an
odd non-classic clinical presentation which was not known
before. Egyptian HCC looks to have unusual presentationsby its tendency to have more aggressive behavior and prefer-
ence to skeletal metastasis, mostly due to early vascular inva-
sion. Underlying genetic abnormality should be stressed in
the future researches, international multicenter studies from
different endemic countries in the world should be carried out
to ﬁgure out these odd non classical presentations.
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